findmyKOL

Nandkishore Ranadive, MD

Basic profile

Interventional Cardiology

ORCIDNone on fileNPI
RegionAltamonte Springs, FL · SoutheastSpecialtyInterventional CardiologyFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2023Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Nandkishore Ranadive is a Cardiology physician. OpenAlex indexes 5 publications with 377 citations (h-index 2).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
5publications

Distinct works indexed by OpenAlex.

377citations

Total citations across indexed works.

2h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
46companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

450 W. Central Pkwy
Suite 2000
Altamonte Springs, FL 32714

Telephone

407-767-8554

Registry record last updated 27 Aug 2015.

View the NPPES registry record

Industry payments

46 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    75.2%
    Statin17.2%
    Rosuvastatin Calcium56%Atorvastatin Calcium39%Simvastatin4%Pravastatin Sodium1%
    Part D<11 patients
    Beta blocker12.4%
    Carvedilol46%Metoprolol Succinate17%Metoprolol Tartrate15%Sotalol10%Atenolol7%Propranolol Hcl3%Atenolol-Chlorthalidone2%Bisoprolol Fumarate2%Sotalol Af1%
    Part D<11 patients

    + 25 more classes in this area

  • Blood & clotting

    11.3%
    Factor Xa inhibitor6.8%
    Eliquis85%Xarelto15%
    Part D180 patients
    P2Y12 inhibitor3.4%
    Clopidogrel96%Brilinta4%
    Part D<11 patients

    + 2 more classes in this area

  • Metabolism & gastrointestinal

    8%
    Biguanide (metformin)1.7%
    Metformin Hcl70%Metformin Hcl Er30%
    Part D41 patients
    Potassium supplement1.6%
    Potassium Chloride92%Klor-Con 108%
    Part D<11 patients

    + 8 more classes in this area

Where care is delivered (Part B)1.5% facility · 98.5% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”